Structure |
Chemical Name |
CAS |
MF |
|
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride |
2143944-64-1 |
C16H21N2S+ |
|
2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione |
1809464-27-4 |
C22H17ClO3 |
|
Aprepitant impurity C |
|
|
|
Ticagrelor Related Compound 14 |
2056269-94-2 |
C23H28F2N6O4S |
|
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
|
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
|
Moxifloxacin EP Impurity D HCl |
|
|
|
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
|
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
|
Apremilast |
1384967-20-7 |
C20H20N2O7S |
|
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
|
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
|
LAT-NET |
607351-44-0 |
C25H39NO4 |
|
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
|
L-GLUCONO-1,5-LACTONE |
52153-09-0 |
C6H10O6 |
|
C-Desmethyl Atenolol |
1797116-92-7 |
C13H20N2O3 |
|
Fenofibric Acid 1-Carboxyl-1-methylethyl Ester |
1797121-54-0 |
C21H21ClO6 |
|
2-Chloro-4'-fluorobenzophenone |
1806-23-1 |
C13H8ClFO |
|
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
|
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
|
Parecoxib Impurity M |
|
|
|
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
|
Linagliptin Impurity O |
|
|
|
Linagliptin Impurity T |
|
|
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
|
Apremilast Impurity 2 |
|
|
|
Etoricoxib Impurity 16 |
|
|
|
Ibrutinib Impurity 2 |
|
|
|
Mirabegron Impurity 14 |
|
|
|
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
|
Atenolol EP Impurity |
|
C14H22N2O3 |
|
Cinacalcet Impurity 20 |
|
|
|
Dapagliflozin Impurity 11 |
|
|
|
Dasatinib Impurity C |
|
|
|
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
|
Flucloxacillin Impurity |
|
|
|
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
|
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
|
Clopidogrel impurity reference substance |
|
C15H14ClNO2S |
|
Vildagliptin Impurity |
|
|
|
Aloeemodin-ω-O-β-D-glucopyranoside |
29010-56-8 |
C21H20O10 |
|
ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
2029205-62-5 |
C26H25ClN4O4 |
|
1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate |
1192651-80-1 |
C23H46N4O6S |
|
Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ) |
|
|
|
cefditoren E-isomer(C=C) |
|
|
|
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
|
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
|
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
|
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
|
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
|
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
|
Moxifloxacin Related Impurity 3 |
|
|
|
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
|
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
|
Levofloxacin N-Oxide |
117678-37-2 |
C18H20FN3O5 |
|
Oseltamivir EP Impurity A |
1391047-93-0 |
C14H24N2O4 |
|
Quetiapine EP Impurity N |
1800291-86-4 |
C29H41N5O3S |
|
Ceftazidime Impurity |
|
|
|
Chlorhexidine Digluconate Impurity N |
152504-10-4 |
C15H25ClN8 |
|
S-Azetidin-3-yl ethanethioate HCl |
886615-18-5 |
C5H9NOS |
|
Olaparib Impurity C |
|
|
|
Olaparib Impurity F |
|
|
|
Dapoxetine Impurity 4 |
|
|
|
Glycopyrrolate impurity 3 |
|
|
|
Lamotrigine impurity B |
|
|
|
Ramosetron Impurity 3 |
|
|
|
Loratadine Impurity 1 |
|
C22H23ClN2O2 |
|
Metoprolol IMpurity 6 |
|
C15H25NO3 |
|
Pitavastatin Impurity 5 |
|
|
|
Prasugrel Impurity C |
|
|
|
Trifluridine Impurity 2 |
|
|
|
Cefazolin Impurity 4 |
|
|
|
Vonoprazan Impurity 3 |
|
|
|
Cinacalcene Impurity I |
|
|
|
Valsartan Impurity 2 |
|
C24H29N5O3 |
|
Istradefylline Impurity 2 |
|
|
|
Etoricoxib Impurity 3 |
|
|
|
Apremilast Impurity 5 |
200710-04-9 |
C11H13NO4 |
|
Topiroxostat Imp.C |
|
|
|
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-08-7 |
C24H21ClFNO3 |
|
Rabeprazole Impurity 2 |
1163685-31-1 |
C11H15NO4 |
|
Regorafenib Impurity 8 |
|
|
|
Flomoxef Impurity 5 |
134237-56-2 |
C25H23ClF2N2O6S |
|
Ranitidine impurity |
94167-82-5 |
C10H18N2O |
|
nicergoline impurity E |
|
|
|
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
|
Tacrolimus Impurity C |
|
|
|
Levodopa impurity 5 |
|
|
|
(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
1223404-68-9 |
C21H22F2N6O2 |
|
Afatinib Impurity 18 |
2316847-95-5 |
C22H20ClFN4O4 |
|
Ivabradine Impurity 1 Hydrochloride |
85175-52-6 |
C16H25ClN2O3 |
|
SofosBuvir Impurity 3 |
|
|
|
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
|
Canagliflozin Impurity 10 |
1672658-93-3 |
C24H25FO6S |
|
Canagliflozin Impurity F |
|
|
|
Empagliflozin impurity E |
|
|
|
Fasudil Impurity 6 |
2044706-58-1 |
C11H11NO3S |
|
Ibrutinib Impurity 11 |
|
|
|
Nintedanib impurity I |
334951-61-0 |
C30H31N5O4 |
|
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
1253768-91-0 |
C16H11NO4 |